A major longitudinal study tracking nearly half a million adolescents has found a stark link between cannabis use in the teenage years and the development of serious psychiatric conditions in young adulthood, raising fresh concerns about the mental health costs of expanding cannabis commercialization.
Researchers followed 463,396 teens aged 13 to 17 through age 26 and discovered that adolescents who reported using cannabis within the past year faced roughly double the risk of later developing psychotic disorders or bipolar disorder. The same group also showed significantly elevated risks for depression and anxiety.
The study, published in JAMA Health Forum, analyzed electronic health records from routine pediatric visits between 2016 and 2023. The researchers, from Kaiser Permanente, UCSF, USC, and the Public Health Institute, found that cannabis use typically preceded psychiatric diagnosis by 1.7 to 2.3 years on average, suggesting a potential causal relationship rather than mere correlation.
The timing matters. Because the study tracked participants forward over time rather than relying on retrospective accounts, it provides stronger evidence that cannabis exposure during the teenage years may actually contribute to the development of mental illness, rather than simply being more common among those already prone to it.
The findings carry weight partly because they extend beyond the narrow slice of heavy users that earlier research had focused on. This study examined any self-reported cannabis use within the past year detected through universal screening in pediatric care. Even after accounting for prior mental health conditions and other substance use, the elevated psychiatric risks remained substantial.
The results arrive at a moment when cannabis products have become far more potent than in previous decades. Average THC levels in California cannabis flower now exceed 20 percent, while some concentrates contain more than 95 percent THC. Meanwhile, cannabis use remains the most commonly used illicit drug among American adolescents, with the most recent national survey finding that more than 10 percent of teens aged 12 to 17 reported use in the past year.
Lynn Silver, program director of the Getting it Right from the Start initiative and a study co-author, called for urgent action in response to the findings. "As cannabis becomes more potent and aggressively marketed, this study indicates that adolescent cannabis use is associated with double the risk of incident psychotic and bipolar disorders, two of the most serious mental health conditions," Silver said, adding that the evidence points toward reducing product potency, prioritizing prevention, and limiting youth marketing exposure.
The research also uncovered troubling disparities. Cannabis use was more common among adolescents enrolled in Medicaid and those living in neighborhoods with greater economic disadvantage, raising concerns that continued cannabis commercialization could widen existing mental health outcome gaps between socioeconomic groups.
Author Jessica Williams: "This study makes a strong case that teen cannabis use deserves serious public health attention, not dismissal as harmless experimentation."
Comments